In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

BMS, QDose end inhaled insulin product deal

Executive Summary

QDose has licensed Bristol-Myers Squibb worldwide exclusive rights to its breath-activated, inhaled insulin product candidate. QDose is a JV owned by drug delivery company MicroDose Technologies and Quadrant Drug Delivery Ltd. (QDD; dry powder pulmonary delivery), the July 2003 management buyout of the former Elan Drug Delivery Ltd.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register